Last reviewed · How we verify

NCT03542968: 4DFlowFallot

Imaging by 4 DFlow in Patients With Tetralogy of Fallot

Status unknown NA Last updated 23 January 2020
What this trial tests

NA trial testing magnetic resonance imaging in Congenital Heart Disease in 30 participants. Status unknown.

Timeline
12 October 2017
Primary endpoint
11 October 2019
11 April 2020

Quick facts

Lead sponsorCentre Chirurgical Marie Lannelongue
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment30
Start date12 October 2017
Primary completion11 October 2019
Estimated completion11 April 2020
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Chirurgical Marie Lannelongue — full company profile →

Who can join

10 and older, any sex, with Congenital Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Conventionnal cadiac magnetic resonance (CMR) is the reference to assess changes in right heart flow and pulmonary artery hemodynamics in patients with repaired Tetralogy of Fallot. 4D Flow CMR Imaging is a new imaging modality able to assess all of these parameters faster (8 min vs 30 min) and more comfortably. The aim of this study is to compare conventionnal CMR and 4D Flow CMR for the assessment of these parameters (ventricular volume, ventricular systolic function, and regurgitation of the pulmonary pathway).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of magnetic resonance imaging

Trials testing the same drug.

Other recruiting trials for Congenital Heart Disease

Currently open trials in the same condition.

Other Centre Chirurgical Marie Lannelongue trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03542968.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing